amperozide has been researched along with raclopride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alster, P; Svensson, TH; Uvnäs-Moberg, K | 1 |
| Lindefors, N; Malmerfelt, A; Marcus, MM; Nomikos, GG; Svensson, TH; Zachrisson, O | 1 |
| Hertel, P; Nomikos, GG; Svensson, TH | 1 |
3 other study(ies) available for amperozide and raclopride
| Article | Year |
|---|---|
Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Female; Haloperidol; Male; Oxytocin; Piperazines; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Serotonin Antagonists | 1992 |
Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat.
Topics: Animals; Antipsychotic Agents; Caudate Nucleus; Clozapine; Dopamine Antagonists; Haloperidol; Male; Nucleus Accumbens; Organ Specificity; Piperazines; Prefrontal Cortex; Protein Precursors; Putamen; Raclopride; Rats; Rats, Sprague-Dawley; RNA, Messenger; Salicylamides; Somatostatin; Tachykinins; Transcription, Genetic | 1997 |
Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
Topics: Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Hydroxyindoleacetic Acid; Idazoxan; Male; Piperazines; Prazosin; Pyridines; Raclopride; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Risperidone; Salicylamides; Serotonin; Serotonin Antagonists | 1997 |